• COVID-19 Experimental Antibody Treatment Reaches Patients

    9 days ago - By Discovery's Edge

    On Thursday, Nov. 19, Mayo Clinic began offering an experimental therapy to patients who test positive for COVID-19 and are at high risk for serious illness. The therapy uses a type of drug called a monoclonal antibody. But what are monoclonal antibodies? To understand this type of drug, Richard Kennedy, Ph.D. , an immunologist and co-director of Mayo Clinic's Vaccine Group, explains how antibodies are used in the body's natural immune response.
    Natural Antibody Response
    The body naturally produces immune proteins, called antibodies, that fight infection. Antibodies are made by B cells...
    Read more ...